Instrument Inactif

Communiqués QuiaPEG Pharmaceuticals Holding AB

Actions

21/02/24	QuiaPEG has submitted a formal application to Nasdaq in relation to the company’s acquisition of intellectual property rights from Rosemonkey Ltd.	AQ
20/02/24	QuiaPEG has submitted a formal application to Nasdaq for the reverse acquisition of Rosemonkey Ltd.	AQ
15/02/24	QuiaPEG och Net Zero Infrastucture take next step to a formal license agreement	AQ
08/11/23	QuiaPEG enters conditional agreement on a reverse takeover and financing to enable continued business development of existing operations	AQ